Journal of Clinical Biochemistry and Nutrition · 2009 · 26 citations · 12 references
Life SciencesNutritionNutritional SciencesClinical NutritionHuman NutritionNutritional BiochemistryBioactive Food ComponentsEssential Fatty AcidsFatty Acid ChemistryLipid MetabolismLipid Metabolism DisordersLipid NutritionDietary Fatty AcidsDocosahexaenoic AcidEicosapentaenoic AcidFatty Acid Composition ImprovementFatty AcidsMortality RatesObstructive JaundiceSupplement Dosage
Nutritional and immunological status of patients with obstructive jaundice is usually severely altered, with high mortality rates. The n-3 polyunsaturate fatty acids (PUFA), particularly eicosapentaenoic acid (EPA, 20:5 n-3), posess potent immunomodulatory activities. Thus, our aim was to compare the plasma phospholipid fatty acid (FA) composition of these patients with healthy subjects, as well as before and after 7 days preoperative supplementation with high doses of EPA (0.9 g per day) and docosahexaenoic acid (DHA, 22:6 n-3, 0.6 g per day). We found impaired FA status in obstructive jaundice patients, especially EPA, DHA and PUFA, but significantly increased content of total n-3 FA, 22:5 n-3 FA and particularly EPA, which increased more than 3 fold, after 7 days supplementation. In addition, the n6/n3 ratio significantly decreased from 14.24 to 10.24, demonstrating severely improved plasma phospholipid profile in these patients after the intervention.
12
Evangeline Mantzioris, LG Cleland, MJ James · American Journal of Clinical Nutrition · 1996 · 863 citations · Full text
Mira Katan, J.P. Deslypère, A P van Birgelen et al. · Journal of Lipid Research · 1997 · 631 citations · Full text